Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric Comparative Study
Not Applicable
Completed
- Conditions
- Chronic Pain
- Interventions
- Drug: epidural transforaminal injection of magnesuim sulfateDrug: epidural transforaminal injection of dexmedtemodine
- Registration Number
- NCT05271721
- Lead Sponsor
- Minia University
- Brief Summary
Transforaminal injection of chronic radicular lower limb injection by either dexmedetomdine or magnesuim sulfate
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
- Age group. 25-75ys old
- Both sex.
- Lumber disc protrusion at one or two segments on MRI.
- Chronic lumbar radiculer pain for more than 6 weeks refractory to
- medical treatment for at least 4 weeks. .
- Positve leg rising test at 30-70 degrees.
Exclusion Criteria
- Diabetic candidates ( type Ior II).
- Patient refusal.
- MRI with disc sequestration.
- Neurological examination revealed foot drop, neuropathic ulcers
- Myelopathic or scoliotic patients, .
- Coagulopathic patients ( cirrhotic patients, on anti-coagulation )
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Magnesuim group epidural transforaminal injection of magnesuim sulfate . 200 mg Mg sulfate (1ml) plus 4 mg dexamethasone(1ml) plus 40mg lidocaine 2% (2ml) Dexmedetomidine group epidural transforaminal injection of dexmedtemodine Dexmedetmodine 50mic (0.5ml) ,4 mg dexamethasone (1ml), 40 mg lidocaine 2% (2ml) added to 4ml total volume with sterile saline . control group transforaminal epidural injection of dexamethasone Dexamethasone 4 mg (1ml) plus 40 mg ( 2ml) lidocaine 2% plus 1ml sterile saline
- Primary Outcome Measures
Name Time Method pain score up to 6 months post-injection visual analogue pain score. pain value of (0 cm) equals no pain , and value of (10 cm) equals worst pain
- Secondary Outcome Measures
Name Time Method functional disability up to 6 months post injection Modified Oswestry Disability Questionnaire....0% to 20%: minimal disability:....21%-40%: moderate disability: 41%-60%: severe disability...61%-80%: crippled
acute complications 6 hours post-injection number of patients developed epidural hematoma by magnetic resonance imaging
Trial Locations
- Locations (1)
Minia University
🇪🇬Minia, Minia University Hospital, Egypt